An algorithm for rapid computational construction of metabolic networks: A cholesterol biosynthesis example

Computers in Biology and Medicine

Volumn 43, Issue 5, 2013, Pages 471-480

  Belič, Aleš ^a   Pompon, Denis ^b   Monostory, Katalin ^c   Kelly, Diane ^d   Kelly, Steven ^d   Rozman, Damjana ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b CNRS   (France)

^c CHEMICAL RESEARCH CENTER   (Hungary)

^d SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Binary coding; Metabolic networks; Modelling; Simulation; Systems biology

Indexed keywords

BINARY CODING; COMPUTATIONAL CONSTRUCTION; ENZYME-SUBSTRATE INTERACTIONS; MATHEMATICAL ALGORITHMS; METABOLIC NETWORK; REFERENCE NETWORK; SIMULATION; SYSTEMS BIOLOGY;

BIOCHEMISTRY; BIOMOLECULES; BIOSYNTHESIS; CHOLESTEROL; COMPUTER SIMULATION; METABOLISM; METABOLITES; MODELS; SIGNAL ENCODING;

ALGORITHMS;

CHOLESTEROL;

ALGORITHM; ARTICLE; CHOLESTEROL SYNTHESIS; MATHEMATICAL ANALYSIS; METABOLISM; PRIORITY JOURNAL;

ALGORITHMS; CHOLESTEROL; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; LANOSTEROL; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; MODELS, MOLECULAR;

EID: 84875935252     PISSN: 00104825     EISSN: 18790534     Source Type: Journal    
DOI: 10.1016/j.compbiomed.2013.02.017     Document Type: Article

References (50)

1. Hellerstein M.K. A critique of the molecular target-based drug discovery paradigm based on principles of metabolic control. advantages of pathway-based discovery. Metab. Eng. 2008, 10:1-9.
2. Papin J.A., Price N.D., Edwards J.S., Palsson B.Ø. The genome-scale metabolic extreme pathway structure in haemophilus influenzae shows significant network redundancy. J. Theor. Biol. 2002, 215:67-82.
3. Nikoloski Z., Grimbs S., May P., Selbig J. Metabolic networks are np-hard to reconstruct. J. Theor. Biol. 2008, 254(4):807-816.
4. Mithani A., Preston G.M., Hein J. A stochastic model for the evolution of metabolic networks with neighbor dependence. Bioinformatics 2009, 25(12):1528-1535.
5. Yip K.Y., Gerstein M. Training set expansion. an approach to improving the reconstruction of biological networks from limited and uneven reliable interactions. Bioinformatics 2009, 25(2):243-250.
6. Ma H., Goryanin I. Human metabolic network reconstruction and its impact on drug discovery and development. Drug Discov. Today 2008, 13(9/10):402-408.
7. Mavrovouniotis M.L., Stephanopoulos G., Stephanopoulos G. Computer-aided synthesis of biochemical pathways. Biotechnol. Bioeng. 1990, 36(11):1119-1132.
8. Mittenthal J.E., Clarke B., Waddell T.G., Fawcett G. A new method for assembling metabolic networks, with application to the krebs citric acid cycle. J. Theor. Biol. 2001, 208:361-382.
9. Mavrovouniotis M.L. Estimation of standard Gibbs energy changes of biotransformations. J. Biol. Chem. 1991, 266(22):14440-14445.
10. Li C., Henry C.S., Jankowski M.D., Ionita J.A., Hatzimanikatis V., Broadbelt L.J. Computational discovery of biochemical routes to specialty chemicals. Chem. Eng. Sci. 2004, 59:5051-5060.
11. Hatzimanikatis V., Li C., Ionita J.A., Henry C.S., Jankowski M.D., Broadbelt L.J. Exploring the diversity of complex metabolic networks. Bioinformatics 2005, 21(8):1603-1609.
12. Yamanishi Y., Hattori M., Kotera M., Goto S., Kanehisa M. E-zyme. predicting potential EC numbers from the chemical transformation pattern of substrate-product pairs. Bioinformatics 2009, 25(12):i179-i186.
13. Moriya Y., Shigemizu D., Hattori M., Tokimatsu T., Kotera M., Goto S., Kanehisa M. Pathpred. an enzyme-catalyzed metabolic pathway prediction server. Nucl. Acids Res. 2010, 38(suppl 2):W138-W143.
14. Ellis L.B.M., Gao J., Fenner K., Wackett L.P. The university of Minnesota pathway prediction system. predicting metabolic logic. Nucl. Acids Res. 2008, 36:W427-W432.
15. Wicker J., Fenner K., Ellis L., Wackett L., Kramer S. Predicting biodegradation products and pathways. a hybrid knowledge-based and machine learning based approach. Bioinformatics 2010, 26:814-821.
16. Kanehisa M., Araki M., Goto S., Hattori M., Hirakawa M., Itoh M., Katayama T., Kawashima S., Okuda S., Tokimatsu T., Yamanishi Y. KEGG for linking genomes to life and the environment. Nucl. Acids Res. 2008, 36:D480-D484.
17. Espenshade P.J., Hughes A.L. Regulation of sterol synthesis in eukaryotes. Annu. Rev. Genet. 2007, 41(1):401-427.
18. Rozman D., Monostory K. Perspectives of the non-statin hypolipidemic agents. Pharmacol. Ther. 2010, 127(1):19-40.
19. Lees N., Bard M., Kirsch D. Biochemistry and molecular biology of sterol synthesis in saccharomyces cerevisiae. Crit. Rev. Biochem. Mol. Biol. 1999, 34(1):33-47.
20. Parker J., Merkamm M., Manning N., Pompon D., Kelly S., Kelly D. Differential azole antifungal efficacies contrasted using a saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus. Antimicrob. Agents Chemother. 2008, 52(10):3597-3603.
21. Rahier A. Deuterated Δ 7-cholestenol analogues as mechanistic probes for wild-type and mutated Δ 7-sterol-c5(6)-desaturase. Biochemistry 2001, 40:256-267.
22. Mercer E.I., Glover J. The interconversion of cholesterol, 7-dehydrocholesterol and lathosterol in the rat. Biochem. J. 1961, 80:552-556.
23. Atanasijević-Kunc M., Drinovec J., Ručigaj S., Mrhar A. Modeling the influence of risk factors and chronic diseases on the development of strokes and peripheral arterial-vascular disease. Simulat. Modell. Pract. 2008, 16(8):998-1013.
24. Atanasijević-Kunc M., Drinovec J., Ručigaj S., Mrhar A. Simulation analysis of coronary heart disease, congestive heart failure and end-stage renal disease economic burden. Math. Comput. Simul. 2011, 82(3):494-507.
25. Bae S.-H., Paik Y.-K. Cholesterol biosynthesis from lanosterol. development of a novel assay method and characterization of rat liver microsomal lanosterol Δ24-reductase. Biochem. J. 1997, 326:609-616.
26. Risley J.M. Cholesterol biosynthesis. lanosterol to cholesterol. J. Chem. Educ. 2002, 79(3):377-384.
27. Skrede S., Björkhem I. Biosynthesis of cholestanol from intestinal 7a-hydroxy-4-cholesten-3-one. J. Biol. Chem. 1982, 257(14):8363-8367.
28. Skrede S., Björkhem I., Buchmann M.S., Hopen G., Fausa O. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated c27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. J. Clin. Invest. 1985, 75(2):448-455.
29. Sedel F., Baumann N., Turpin J.-C., Lyon-Caen O., Saudubray J.-M., Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J. Inherit. Metab. Dis. 2007, 30:631-641.
30. Pilo de la Fuente B., Ruiz I., Lopez de Munain A., Jimenez-Escrig A. Cerebrotendinous xanthomatosis. neuropathological findings. J. Neurol. 2008, 255(6):839-842.
31. Gallus G.N., Dotti M.T., Federico A. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the cyp27a1 gene. Neurol. Sci. 2006, 27:143-149.
32. 7-reductase. J. Biochem. Mol. Biol. 1997, 30(5):370-377.
33. Javitt N.B. Oxysterols. novel biologic roles for the 21st century. Steroids 2008, 73:149-157.
34. Watkinson I.A., Wilton D.C., Munday K.A., Akhtar M. The formation and reduction of the 14,15-double bond in cholesterol biosynthesis. Biochem. J. 1971, 121:131-137.
35. Lutsky B.N., Martin J.A., Schroepfer G.J. Studies of the metabolism of 5α-cholesta-8, 14-dien-3Β-ol and 5α-cholesta-7, 14-dien-3Β-ol in rat liver homogenate preparations. J. Biol. Chem. 1971, 246:6737-6744.
36. Chan J.T., Spike T.E., Trowbridge S.T., Schroepfer G.J. Sterol synthesis. studies of the metabolism of 14α-methyl-5α-cholest-7-en-3Β-ol. J. Lipid Res. 1979, 20:1007-1019.
37. Smith A.G., Goad L.J. Sterol biosynthesis in the starfish asterias rubens and henricia sanguinolenta. Biochem. J. 1971, 123:671-673.
38. Hsiung H.M., Spike T.E., Schroepfer G.J. Enzymatic conversion of 5α-cholesta-7, 14-dien-3Β-ol to 5α-cholesta-8, 14-dien-3Β-ol. Lipids 1975, 10:623-626.
39. 24(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of leishmania amazonensis. Antimicrob. Agents Chemother. 2002, 46:487-499.
40. W. deSouza, J.C.F. Rodrigues, Sterol biosynthesis pathway as target for anti-trypanosomatid drugs, Interdiscip. Perspect. Infect. Dis. 2009 (2009) 19pp. doi:10.1155/2009/642502.
41. Koul A., Vitullo J., Reyes G., Ghannoum M. Effects of voriconazole on candida glabrata in vitro. J. Antimicrob. Chemother. 1999, 44:109-122.
42. Xu R., Wilson W.K., Matsuda S.P.T. Production of meiosis-activating sterols from metabolically engineered yeast. J. Am. Chem. Soc. 2002, 124:918-919.
43. Eneroth P., Gustafsson J.-Å., Nyström E. Steroids in newborns and infants. Eur. J. Biochem. 1969, 11:456-464.
44. Ramsey R.B., Aexel R.T., Nicholas H.J. Formation of methyl sterols in brain cholesterol biosynthesis. J. Biol. Chem. 1971, 246:6393-6400.
45. Scallen T.J., Dhar A.K., Loughran E.D. Isolation and characterization of c-4 methyl intermediates in cholesterol biosynthesis after treatment of rat liver in vitro with cholestan-3Β, 5α, 6Β-triol. J. Biol. Chem. 1971, 2:3168-3174.
46. Singh D.K., Porter T.D. Inhibition of sterol 4a-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J. Nutr. 2006, 136:759S-764S.
47. Jahnke L.L., Summons R.E., Dowling L.M., Zahiralis K.D. Identification of methanotrophic lipid biomarkers in cold-seep mussel gills. chemical and isotopic analysis. Appl. Environ. Microbiol. 1995, 61:576-582.
48. Martin J., Lopez P. Age-related variation in lipophilic chemical compounds from femoral gland secretions of male lizards psammodromus algirus. Biochem. Syst. Ecol. 2006, 34:691-697.
49. Cabrera-Vivas B.M., Gonzalez C.M., Melendrez R.M., Martinez-Aguilera L.M.R., Ramirez J.C. Theoretical study of the 4α-demethylation mechanism involved in the biosynthesis of cholesterol. J. Mol. Struct. (theochem) 2003, 625:149-159.
50. Santos V.L.C.S., Billett D.S.M., Wolff G.A. An unusual 4-methyl sterol present in abyssal sediments from the north-east atlantic ocean. Aquat. Ecosyst. Health 2000, 3:397-405.